Levobupivacaine - A review of its pharmacology and use as a local anaesthetic

被引:268
作者
Foster, RH [1 ]
Markham, A [1 ]
机构
[1] Adis Int Ltd, Auckland 10, New Zealand
关键词
D O I
10.2165/00003495-200059030-00013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Based an findings that the cardiotoxicity infrequently observed with racemic bupivacaine shows enantioselectivity, i,e, it is more pronounced with the R(+)-enantiomer, the S(-)-enantiomer (levobupivacaine) has been developed for clinical use as a long acting local anaesthetic. The majority of in vitro, in vitro and human pharmacodynamic studies of nerve block indicate that levobupivacaine has similar potency to bupivacaine. However, levobupivacaine had a lower risk of cardiovascular and CNS toxicity than bupivacaine in animal studies. In human volunteers, levobupivacaine had less of a negative inotropic effect and, at intravenous doses >75mg, produced less prolongation of the QT(C) interval than bupivacaine. Fewer changes indicative of CNS depression on EEG were evident with levobupivacaine. Levobupivacaine is long acting with a dose-dependent duration of anaesthesia. The onset of action is less than or equal to 15 minutes with various anaesthetic techniques, In studies of surgical anaesthesia in adults, levobupivacaine provided sensory block for up to 9 hours after epidural administration of less than or equal to 202.5mg, 6.5 hours after intrathecal 15mg, and 17 hours after brachial plexus block with 2 mg/kg. Randomised, double-blind clinical studies established that the anaesthetic and/or analgesic effects of levobupivacaine were largely similar to those of bupivacaine at the same dose. Sensory block tended to be longer with levobupivacaine than bupivacaine, amounting to a difference of 13 to 45 minutes with epidural administration and approximately 2 hours with peripheral nerve block. With epidural administration, levobupivacaine produced less prolonged motor block than sensory block. This differential was not seen with peripheral nerve block. Conditions satisfactory for surgery and good pain management were achieved by use of local infiltration or peribulbar administration of levobupivacaine, Levobupivacaine was generally as effective as bupivacaine for pain management during labour, and was effective for the management of postoperative pain, especially when combined with clonidine, morphine or fentanyl. The tolerability profiles of levobupivacaine and bupivacaine were very similar in clinical trials. No clinically significant ECG abnormalities or serious CNS events occurred with the doses used. The most common adverse event associated with levobupivacaine treatment was hypotension (31%). Conclusions: Levobupivacaine is a long acting local anaesthetic with a clinical profile closely resembling that of bupivacaine. However, current preclinical safety and toxicity data show an advantage for levobupivacaine over bupivacaine. Clinical data comparing levobupivacaine with ropivacaine are needed before the role of the drug can be fully established. Excluding pharmacoeconomic considerations, levobupivacaine is an appropriate choice for use in place of bupivacaine.
引用
收藏
页码:551 / 579
页数:29
相关论文
共 71 条
[1]  
Abbott Laboratories, 1999, CHIR 2 5 MG ML SUMM
[2]   TOXICOLOGICAL AND LOCAL ANESTHETIC EFFECTS OF OPTICALLY ACTIVE ISOMERS OF 2 LOCAL ANESTHETIC COMPOUNDS [J].
ABERG, G .
ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1972, 31 (04) :273-&
[3]   Epidural analgesics - How can safety and efficacy be improved? [J].
Albaladejo, P ;
Bouaziz, H ;
Benhamou, D .
CNS DRUGS, 1998, 10 (02) :91-104
[4]   CARDIAC-ARREST FOLLOWING REGIONAL ANESTHESIA WITH ETIDOCAINE OR BUPIVACAINE [J].
ALBRIGHT, GA .
ANESTHESIOLOGY, 1979, 51 (04) :285-287
[5]   INTRADERMAL STUDY OF LOCAL-ANESTHETIC AND VASCULAR EFFECTS OF ISOMERS OF BUPIVACAINE [J].
APS, C ;
REYNOLDS, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (01) :63-68
[6]   Clinical effects and maternal and fetal plasma concentrations of 0.5% epidural levobupivacaine versus bupivacaine for cesarean delivery [J].
Bader, AM ;
Tsen, LC ;
Camann, WR ;
Nephew, E ;
Datta, S .
ANESTHESIOLOGY, 1999, 90 (06) :1596-1601
[7]  
Bardsley H, 1997, Expert Opin Investig Drugs, V6, P1883, DOI 10.1517/13543784.6.12.1883
[8]   A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers [J].
Bardsley, H ;
Gristwood, R ;
Baker, H ;
Watson, N ;
Nimmo, W .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (03) :245-249
[9]   Levobupivacaine vs bupivacaine as infiltration anaesthesia in inguinal herniorrhaphy [J].
Bay-Nielsen, M ;
Klarskov, B ;
Bech, K ;
Andersen, J ;
Kehlet, H .
BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 (02) :280-282
[10]  
*BRIT MED ASS ROYA, 1999, BRIT NAT FORM, V38